Alto Neuroscience, Inc.
(ANRO - NYSE)
35,55 USD
📋 Profilo Aziendale

Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications.

|